Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of Perampanel as adjunctive therapy in pediatric epilepsy with partial-onset seizures; recruitment is ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Perampanel (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Pediatric Epileptic Syndrome, Partial-onset Seizures | Phase 2 | Status: RECRUITING